Kim G Smolderen1, Kensey Gosch2, Manesh Patel2, W Schuyler Jones2, Alan T Hirsch2, John Beltrame2, Rob Fitridge2, Mehdi H Shishehbor2, Johan Denollet2, Patrick Vriens2, Jan Heyligers2, Nancy Stone MEd2, Herbert Aronow2, J Dawn Abbott2, Clementine Labrosciano2, Rudolf Tutein-Nolthenius2, John A Spertus2. 1. From the Department of Biomedical & Health Informatics, University of Missouri Kansas City (K.G.S., J.S.); Saint Luke's Mid America Heart Institute, Kansas City, MO (K.G.S., K.G., N.S., J.S.); Department of Cardiology, Duke University School of Medicine, Durham, NC (M.P., S.J.); Department of Cardiology, University of Minnesota, Minneapolis (A.T.H.); Departments of Cardiology and Vascular Surgery, Queen Elisabeth Hospital, Adelaide, Australia (J.B., R.F., C.L.); Department of Cardiology, University Hospitals of Cleveland, OH (M.H.S.); Department of Medical Psychology, Tilburg University, The Netherlands (J.D.); Department of Vascular Surgery, St. Elisabeth Hospital, Tilburg, The Netherlands (P.V., J.H.); and Department of Cardiology, Rhode Island Hospital, Providence (H.A., D.A.). smolderenk@umkc.edu. 2. From the Department of Biomedical & Health Informatics, University of Missouri Kansas City (K.G.S., J.S.); Saint Luke's Mid America Heart Institute, Kansas City, MO (K.G.S., K.G., N.S., J.S.); Department of Cardiology, Duke University School of Medicine, Durham, NC (M.P., S.J.); Department of Cardiology, University of Minnesota, Minneapolis (A.T.H.); Departments of Cardiology and Vascular Surgery, Queen Elisabeth Hospital, Adelaide, Australia (J.B., R.F., C.L.); Department of Cardiology, University Hospitals of Cleveland, OH (M.H.S.); Department of Medical Psychology, Tilburg University, The Netherlands (J.D.); Department of Vascular Surgery, St. Elisabeth Hospital, Tilburg, The Netherlands (P.V., J.H.); and Department of Cardiology, Rhode Island Hospital, Providence (H.A., D.A.).
Abstract
BACKGROUND: Health status outcomes, including symptoms, functional status, and quality of life, are critically important outcomes from patients' perspectives. The PORTRAIT study (Patient-Centered Outcomes Related to Treatment Practices in Peripheral Arterial Disease: Investigating Trajectories) was designed to prospectively define health status outcomes and examine associations between patients' characteristics and care to these outcomes among those presenting with new-onset or worsened claudication. METHODS AND RESULTS: PORTRAIT screened 3637 patients with an abnormal ankle-brachial index and new, or worsened, claudication symptoms from 16 peripheral arterial disease (PAD) specialty clinics in the United States, the Netherlands, and Australia between June 2, 2011, and December 3, 2015. Of the 1608 eligible patients, 1275 (79%) were enrolled. Before treatment, patients were interviewed to obtain their demographics, PAD symptoms and health status, psychosocial characteristics, preferences for shared decision-making, socioeconomic, and cardiovascular risk factors. Patients' medical history, comorbidities, and PAD diagnostic information were abstracted from patients' medical records. Serial information about patients' health status, psychosocial, and lifestyle factors was collected at 3, 6, and 12 months by a core laboratory. Follow-up rates ranged from 84.2% to 91%. Clinical follow-up for PAD-related hospitalizations and major cardiovascular events is ongoing. CONCLUSIONS: PORTRAIT systematically collected serial PAD-specific health status data as a foundation for risk stratification, comparative effectiveness studies, and clinicians' adherence to quality-based performance measures. CLINICAL TRIAL REGISTRATION: URL: https://www.clinicaltrials.gov. Unique identifier: NCT01419080.
BACKGROUND: Health status outcomes, including symptoms, functional status, and quality of life, are critically important outcomes from patients' perspectives. The PORTRAIT study (Patient-Centered Outcomes Related to Treatment Practices in Peripheral Arterial Disease: Investigating Trajectories) was designed to prospectively define health status outcomes and examine associations between patients' characteristics and care to these outcomes among those presenting with new-onset or worsened claudication. METHODS AND RESULTS: PORTRAIT screened 3637 patients with an abnormal ankle-brachial index and new, or worsened, claudication symptoms from 16 peripheral arterial disease (PAD) specialty clinics in the United States, the Netherlands, and Australia between June 2, 2011, and December 3, 2015. Of the 1608 eligible patients, 1275 (79%) were enrolled. Before treatment, patients were interviewed to obtain their demographics, PAD symptoms and health status, psychosocial characteristics, preferences for shared decision-making, socioeconomic, and cardiovascular risk factors. Patients' medical history, comorbidities, and PAD diagnostic information were abstracted from patients' medical records. Serial information about patients' health status, psychosocial, and lifestyle factors was collected at 3, 6, and 12 months by a core laboratory. Follow-up rates ranged from 84.2% to 91%. Clinical follow-up for PAD-related hospitalizations and major cardiovascular events is ongoing. CONCLUSIONS: PORTRAIT systematically collected serial PAD-specific health status data as a foundation for risk stratification, comparative effectiveness studies, and clinicians' adherence to quality-based performance measures. CLINICAL TRIAL REGISTRATION: URL: https://www.clinicaltrials.gov. Unique identifier: NCT01419080.
Authors: Ali O Malik; Kensey Gosch; Merrill B Thomas; Carlos Mena-Hurtado; William Hiatt; Herbert D Aronow; Phillip G Jones; Jeremy Provance; Clementine Labrosciano; Qurat-Ul-Ain Jelani; John A Spertus; Kim G Smolderen Journal: J Psychosom Res Date: 2020-11-24 Impact factor: 3.006
Authors: Yevgeniy Khariton; Krishna K Patel; Paul S Chan; Yashashwi Pokharel; Jingyan Wang; John A Spertus; David M Safley; William R Hiatt; Kim G Smolderen Journal: Clin Cardiol Date: 2018-10-19 Impact factor: 2.882
Authors: Kim G Smolderen; Christina Pacheco; Jeremy Provance; Nancy Stone; Christine Fuss; Carole Decker; Matthew Bunte; Qurat-Ul-Ain Jelani; David M Safley; Eric Secemsky; Karen R Sepucha; Erica S Spatz; Carlos Mena-Hurtado; John A Spertus Journal: Vasc Med Date: 2021-02-25 Impact factor: 3.239
Authors: Poghni A Peri-Okonny; Jingyan Wang; Kensey L Gosch; Manesh R Patel; Mehdi H Shishehbor; David L Safley; J Dawn Abbott; Herbert D Aronow; Carlos Mena-Hurtado; Qurat-Ul-Ain Jelani; Yuanyuan Tang; Matthew Bunte; Clementine Labrosciano; John F Beltrame; John A Spertus; Kim G Smolderen Journal: Circ Cardiovasc Qual Outcomes Date: 2021-05-05
Authors: Poghni A Peri-Okonny; Sarthak Patel; John A Spertus; Elizabeth A Jackson; Ali O Malik; Jeremy Provance; Carlos Mena-Hurtado; Mehdi H Shishehbor; Vittal Hijjaji; Kensey L Gosch; Kim G Smolderen Journal: Am J Cardiol Date: 2020-10-13 Impact factor: 2.778
Authors: Krishna K Patel; Philip G Jones; Edward F Ellerbeck; Donna M Buchanan; Paul S Chan; Christina M Pacheco; Gregory Moneta; John A Spertus; Kim G Smolderen Journal: J Am Heart Assoc Date: 2018-10-16 Impact factor: 5.501
Authors: John T Saxon; David M Safley; Carlos Mena-Hurtado; Jan Heyligers; Robert Fitridge; Mehdi Shishehbor; John A Spertus; Kensey Gosch; Manesh R Patel; Kim G Smolderen Journal: J Am Heart Assoc Date: 2020-01-24 Impact factor: 5.501
Authors: Krishna K Patel; Hani Alturkmani; Kensey Gosch; Carlos Mena-Hurtado; Mehdi H Shishehbor; Poghni A Peri-Okonny; Mark A Creager; John A Spertus; Kim G Smolderen Journal: J Am Heart Assoc Date: 2020-11-06 Impact factor: 5.501